Ilex Medical Ltd (TLV:ILX)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
6,013.00
-60.00 (-0.99%)
Apr 6, 2026, 2:24 PM IDT
Market Cap672.63M -17.7%
Revenue (ttm)930.83M +1.1%
Net Income55.56M +42.5%
EPS4.97 +42.4%
Shares Out11.19M
PE Ratio12.10
Forward PEn/a
Dividend1.22 (2.03%)
Ex-Dividend DateApr 10, 2026
Volume4,430
Average Volume2,072
Open6,073.00
Previous Close6,073.00
Day's Range5,878.00 - 6,073.00
52-Week Range5,463.00 - 7,085.00
Beta-0.11
RSI51.91
Earnings DateApr 3, 2026

About Ilex Medical

Ilex Medical Ltd engages in import, marketing, distribution, and sale of diagnostic products, kits, and consumables in Israel, South Africa, and internationally. The company offers microbiology, chemistry, molecular biology, immunochemistry, and blood banking solutions. It also offers coagulation, hematology, blood gases, bilirubin, biomarkers, fertility, cellular medicine, occult blood, calprotectin, LIS, urine microscopy, osmolarity, and genetic laboratory services. In addition, the company offers medical automation solutions for microbiology... [Read more]

Sector Healthcare
Founded 1977
Employees 178
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol ILX
Full Company Profile

Financial Performance

In 2025, Ilex Medical's revenue was 930.83 million, an increase of 1.14% compared to the previous year's 920.37 million. Earnings were 55.56 million, an increase of 42.52%.

Financial Statements